West Pharmaceutical Services, Inc.
WST
$230.11
$6.382.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 130.10M | 136.00M | 111.30M | 115.30M | 137.00M |
| Total Depreciation and Amortization | 40.70M | 40.20M | 38.90M | 35.60M | 35.90M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.20M | 4.00M | 700.00K | 1.90M | 39.30M |
| Change in Net Operating Assets | 23.50M | -100.00K | 14.10M | -34.60M | 26.90M |
| Cash from Operations | 190.10M | 180.10M | 165.00M | 118.20M | 239.10M |
| Capital Expenditure | -104.90M | -81.30M | -100.20M | -90.60M | -108.70M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00K | -800.00K | -1.00M | -- | -100.00K |
| Cash from Investing | -104.80M | -82.10M | -101.20M | -90.60M | -108.80M |
| Total Debt Issued | 0.00 | 129.70M | 35.00M | -- | -- |
| Total Debt Repaid | -100.00K | -133.20M | -58.40M | -600.00K | -700.00K |
| Issuance of Common Stock | 3.10M | 6.00M | 6.80M | 16.80M | 3.10M |
| Repurchase of Common Stock | -54.60M | -52.40M | -187.20M | -272.40M | -177.10M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -15.30M | -14.50M | -14.60M | -14.70M | -14.80M |
| Other Financing Activities | -2.00M | -- | 100.00K | -100.00K | -- |
| Cash from Financing | -68.90M | -64.40M | -218.30M | -271.00M | -189.50M |
| Foreign Exchange rate Adjustments | -22.70M | 11.10M | -1.10M | -8.70M | 14.50M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.30M | 44.70M | -155.60M | -252.10M | -44.70M |
